Literature DB >> 22379

Megaloblastic anaemia associated with sulphasalazine treatment.

S P Kane, M A Boots.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 22379      PMCID： PMC1632479          DOI： 10.1136/bmj.2.6097.1287-a

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  1 in total

1.  Megaloblastic anaemia associated with sulphasalazine treatment.

Authors:  R E Schneider; L Beeley
Journal:  Br Med J       Date:  1977-06-25
  1 in total
  4 in total

Review 1.  Sulfasalazine. Adverse effects and desensitization.

Authors:  S L Taffet; K M Das
Journal:  Dig Dis Sci       Date:  1983-09       Impact factor: 3.199

2.  Role of sulphasalazine in the aetiology of folate deficiency in ulcerative colitis.

Authors:  C M Swinson; J Perry; M Lumb; A J Levi
Journal:  Gut       Date:  1981-06       Impact factor: 23.059

3.  Sulphasalazine associated pancytopenia may be caused by acute folate deficiency.

Authors:  E C Logan; L M Williamson; D R Ryrie
Journal:  Gut       Date:  1986-07       Impact factor: 23.059

4.  Megaloblastic anaemia due to sulphasalazine responding to drug withdrawal alone.

Authors:  A Grieco; S Caputo; A Bertoli; P Caradonna; A V Greco
Journal:  Postgrad Med J       Date:  1986-04       Impact factor: 2.401
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.